DK0384842T3 - 19-nor-steroider substitueret i 11beta-stillingen med en carbonkæde med en amid- eller carbamatgruppe, deres fremstillingsmetode og mellemprodukter med denne fremstillingsmetode, deres anvendelse som lægemidler og farmaceutiske præparater med indhold deraf - Google Patents

19-nor-steroider substitueret i 11beta-stillingen med en carbonkæde med en amid- eller carbamatgruppe, deres fremstillingsmetode og mellemprodukter med denne fremstillingsmetode, deres anvendelse som lægemidler og farmaceutiske præparater med indhold deraf

Info

Publication number
DK0384842T3
DK0384842T3 DK90400493.4T DK90400493T DK0384842T3 DK 0384842 T3 DK0384842 T3 DK 0384842T3 DK 90400493 T DK90400493 T DK 90400493T DK 0384842 T3 DK0384842 T3 DK 0384842T3
Authority
DK
Denmark
Prior art keywords
alkyl
optionally
preparation
compositions containing
substituted
Prior art date
Application number
DK90400493.4T
Other languages
Danish (da)
English (en)
Inventor
Daniel Philibert
Lucien Nedelec
Andre Claussner
Patrick Van De Velde
Original Assignee
Roussel Uclaf
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Roussel Uclaf filed Critical Roussel Uclaf
Application granted granted Critical
Publication of DK0384842T3 publication Critical patent/DK0384842T3/da

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J1/00—Normal steroids containing carbon, hydrogen, halogen or oxygen, not substituted in position 17 beta by a carbon atom, e.g. estrane, androstane
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J41/00—Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring
    • C07J41/0033—Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring not covered by C07J41/0005
    • C07J41/0077—Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring not covered by C07J41/0005 substituted in position 11-beta by a carbon atom, further substituted by a group comprising at least one further carbon atom
    • C07J41/0083—Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring not covered by C07J41/0005 substituted in position 11-beta by a carbon atom, further substituted by a group comprising at least one further carbon atom substituted in position 11-beta by an optionally substituted phenyl group not further condensed with other rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J41/00—Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring
    • C07J41/0033—Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring not covered by C07J41/0005
    • C07J41/0077—Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring not covered by C07J41/0005 substituted in position 11-beta by a carbon atom, further substituted by a group comprising at least one further carbon atom
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J43/00—Normal steroids having a nitrogen-containing hetero ring spiro-condensed or not condensed with the cyclopenta(a)hydrophenanthrene skeleton
    • C07J43/003—Normal steroids having a nitrogen-containing hetero ring spiro-condensed or not condensed with the cyclopenta(a)hydrophenanthrene skeleton not condensed

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Diabetes (AREA)
  • Endocrinology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Steroid Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Saccharide Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Other Investigation Or Analysis Of Materials By Electrical Means (AREA)
DK90400493.4T 1989-02-24 1990-02-22 19-nor-steroider substitueret i 11beta-stillingen med en carbonkæde med en amid- eller carbamatgruppe, deres fremstillingsmetode og mellemprodukter med denne fremstillingsmetode, deres anvendelse som lægemidler og farmaceutiske præparater med indhold deraf DK0384842T3 (da)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR8902384A FR2643638B1 (fr) 1989-02-24 1989-02-24 Nouveaux 19-nor steroides ayant en position 11beta une chaine carbonee comportant une fonction amide ou carbamate, leur procede de preparation et les intermediaires de ce procede, leur application comme medicaments et les compositions pharmaceutiques les contenant

Publications (1)

Publication Number Publication Date
DK0384842T3 true DK0384842T3 (da) 1994-03-28

Family

ID=9379072

Family Applications (1)

Application Number Title Priority Date Filing Date
DK90400493.4T DK0384842T3 (da) 1989-02-24 1990-02-22 19-nor-steroider substitueret i 11beta-stillingen med en carbonkæde med en amid- eller carbamatgruppe, deres fremstillingsmetode og mellemprodukter med denne fremstillingsmetode, deres anvendelse som lægemidler og farmaceutiske præparater med indhold deraf

Country Status (23)

Country Link
US (2) US5149696A (hu)
EP (1) EP0384842B1 (hu)
JP (1) JP3009169B2 (hu)
KR (1) KR910015590A (hu)
CN (1) CN1046166A (hu)
AT (1) ATE99320T1 (hu)
AU (1) AU631853B2 (hu)
CA (1) CA2010826A1 (hu)
DE (1) DE69005480T2 (hu)
DK (1) DK0384842T3 (hu)
ES (1) ES2062431T3 (hu)
FI (1) FI900925A0 (hu)
FR (1) FR2643638B1 (hu)
HU (1) HU207341B (hu)
IE (1) IE63483B1 (hu)
IL (1) IL93500A0 (hu)
MA (1) MA21754A1 (hu)
MX (1) MX19599A (hu)
OA (1) OA09195A (hu)
PL (1) PL162151B1 (hu)
PT (1) PT93263B (hu)
TN (1) TNSN90018A1 (hu)
ZA (1) ZA901356B (hu)

Families Citing this family (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2650748B1 (fr) * 1989-08-08 1991-11-08 Roussel Uclaf Nouveaux esters d'acides organiques avec des alcools derives de 19-nor steroides et leurs sels, leur procede de preparation et les intermediaires de ce procede, leur application a titre de medicaments et les compositions les renfermant
DE69128820T2 (de) * 1990-08-14 1998-06-10 Hoechst Marion Roussel Inc Neue 19-Nor Steroide, die eine Amid tragende Gruppe in der 11-Beta-Stelle haben, ihre Herstellung, ihre Verwendung als Medikamente und pharmazeutische Präparate davon
GB9126766D0 (en) * 1991-12-17 1992-02-12 Coombes Raoul C D Pharmaceutical compositions
FR2685332A1 (fr) * 1991-12-20 1993-06-25 Roussel Uclaf Nouveaux 19-nor sterouides ayant en position 11beta une chaine thiocarbonee, leur procede de preparation et les intermediaires et leur application a titre de medicaments.
FR2700548B1 (fr) * 1993-01-20 1995-03-03 Roussel Uclaf Nouveau procédé de préparation de stéroïdes 16 alpha-méthylés.
FR2706454B1 (fr) * 1993-06-17 1995-09-15 Roussel Uclaf Nouveaux 19-Nor stéroïdes, procédé et intermédiaires de préparation, application comme médicaments et compositions pharmaceutiques les contenant.
EP0683172B1 (en) * 1994-05-19 1997-08-13 Akzo Nobel N.V. 11,21-Bisphenyl-19-norpregnane derivatives
JP3744559B2 (ja) * 1995-03-17 2006-02-15 独立行政法人情報通信研究機構 立体カメラ、立体ディスプレイ、及び、立体映像システム
US5929262A (en) * 1995-03-30 1999-07-27 The United States Of America As Represented By The Department Of Health And Human Services Method for preparing 17α-acetoxy-11β-(4-N, N-dimethylaminophyl)-19-Norpregna-4,9-diene-3, 20-dione, intermediates useful in the method, and methods for the preparation of such intermediates
FR2757519B1 (fr) 1996-12-23 1999-06-11 Hoechst Marion Roussel Inc Steroides substitues en position 11, leur procede de preparation, leur application comme medicament et les compositions pharmaceutiques les renfermant
DE19724187A1 (de) 1997-06-02 1998-12-03 Schering Ag 11beta-Arylsubstituierte 14,17-Ethanoestratriene, Verfahren zur Herstellung dieser Verbindungen, sowie ihre Verwendung zur Herstellung von Arzneimitteln
FR2771096B1 (fr) * 1997-11-17 2000-08-11 Hoechst Marion Roussel Inc Nouveaux 19-nor steroides, substitues en position 11beta, procede et intermediaires de preparation, application comme medicaments et compositions pharmaceutiques les renfermant
US6262042B1 (en) 1998-05-29 2001-07-17 Research Triangle Institute 17β-amino and hydroxylamino-11β-arylsteroids and their derivatives having agonist or antagonist hormonal properties
FR2789993B1 (fr) * 1999-02-22 2003-03-07 Hoechst Marion Roussel Inc Nouveaux derives de steroides, leurs procedes de preparation et intermediaires de ce procede, leur application a titre de medicaments et compositions pharmaceutiques les renfermant
DE19929715A1 (de) 1999-06-24 2000-12-28 Schering Ag 11ß-langkettig-substituierte Estratriene, Verfahren zur Herstellung , pharmazeutische Präparate, die diese 11ß-langkettig-substituierten Estratriene enthalten, sowie deren Verwendung zur Herstellung von Arzneimitteln
FR2826004B1 (fr) * 2001-06-13 2008-03-28 Aventis Pharma Sa Procede de preparation de derives estrogenes
EP1452293A1 (en) * 2003-02-25 2004-09-01 Mold-Masters Limited Injection molding system with flow control and method of injection molding
DE102009034367A1 (de) * 2009-07-20 2011-01-27 Bayer Schering Pharma Aktiengesellschaft 17-Hydroxy-17-pentafluorethyl-estra-4,9(10)-dien-11-benzyliden-Derivate, Verfahren zu deren Herstellung und deren Verwendung zur Behandlung von Krankheiten
CA2813433C (en) 2010-10-27 2019-08-20 Dignity Health Trimegestone (tmg) for treatment of preterm birth

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2235949B1 (hu) * 1973-06-18 1978-03-17 Roussel Uclaf
ZA8231B (en) * 1981-01-09 1982-11-24 Roussel Uclaf New 11 -substituted steroid derivatives, their preparation, their use as medicaments, the compositions containing them and the new intermediates thus obtained
FR2522328B1 (fr) * 1982-03-01 1986-02-14 Roussel Uclaf Nouveaux produits derives de la structure 3-ceto 4,9 19-nor steroides, leur procede de preparation et leur application comme medicaments
GB8327256D0 (en) * 1983-10-12 1983-11-16 Ici Plc Steroid derivatives
AU580843B2 (en) * 1985-02-07 1989-02-02 Schering Aktiengesellschaft 11``-phenyl-gonanes, their manufacture and pharmaceutical preparations containing them
GB8513723D0 (en) * 1985-05-31 1985-07-03 Erba Farmitalia 11-beta substituted steroids
DE3621024C2 (de) * 1986-06-20 1999-10-28 Schering Ag 11beta-Phenylestradiene, deren Herstellung und diese enthaltende pharmazeutische Präparate

Also Published As

Publication number Publication date
CA2010826A1 (fr) 1990-08-24
IE900662L (en) 1990-08-24
ZA901356B (en) 1991-04-24
HU900273D0 (en) 1990-03-28
IE63483B1 (en) 1995-05-03
CN1046166A (zh) 1990-10-17
JP3009169B2 (ja) 2000-02-14
EP0384842B1 (fr) 1993-12-29
US5290771A (en) 1994-03-01
US5149696A (en) 1992-09-22
AU631853B2 (en) 1992-12-10
PT93263B (pt) 1996-01-31
DE69005480D1 (de) 1994-02-10
EP0384842A1 (fr) 1990-08-29
MX19599A (es) 1994-04-29
TNSN90018A1 (fr) 1991-03-05
PL162151B1 (en) 1993-09-30
OA09195A (fr) 1992-06-30
KR910015590A (ko) 1991-09-30
HU207341B (en) 1993-03-29
FR2643638B1 (fr) 1991-06-14
AU5007290A (en) 1990-08-30
JPH02268194A (ja) 1990-11-01
DE69005480T2 (de) 1994-05-19
PL283941A1 (en) 1991-01-14
MA21754A1 (fr) 1990-10-01
HUT55032A (en) 1991-04-29
FR2643638A1 (fr) 1990-08-31
PT93263A (pt) 1990-08-31
ATE99320T1 (de) 1994-01-15
IL93500A0 (en) 1990-11-29
ES2062431T3 (es) 1994-12-16
FI900925A0 (fi) 1990-02-23

Similar Documents

Publication Publication Date Title
DK0384842T3 (da) 19-nor-steroider substitueret i 11beta-stillingen med en carbonkæde med en amid- eller carbamatgruppe, deres fremstillingsmetode og mellemprodukter med denne fremstillingsmetode, deres anvendelse som lægemidler og farmaceutiske præparater med indhold deraf
FI893750A0 (fi) Menetelmä valmistaa terapeuttisesti aktiivista makrosyklistä johdannaista
ATE127797T1 (de) Aminocoumaranderivate, ihre herstellung und verwendung.
DK154561C (da) Analogifremgangsmaade til fremstilling af antivirale 9-substituerede 2-aminopurinderivater eller fysiologisk acceptable salte eller estere deraf
DK0972762T3 (da) Hidtil ukendte strukturelle analoger af vitamin D
DE69030206D1 (de) Pyrazolopyridinverbindungen und Verfahren zu ihrer Herstellung
DE68922405D1 (de) Deletionsanaloga von magaininpeptiden.
AU6476394A (en) 19-nor steroids having a phenoxyalkylsulphonamide or phenoxyalkylsulphonylurea chain in position 11beta, preparation process and intermediates, use as medicaments and pharmaceutical compositions containing them
KR930016402A (ko) 항-hiv 활성을 갖는 이미다졸 유도체
PT96164A (pt) Processo de preparacao de uma composicao farmaceutica a base de derivados de fluoroquinolona
DK0471612T3 (da) Nye 19-nor steroider med carbonkæde omfattende en amidgruppe i 11-beta-stillingen, fremgangsmåde til deres fremstilling, de
ATE58532T1 (de) (2-amino-4-aryl-thiazol-5-yl)aethanol, und deren derivate mit diuretischer aktivitaet und verfahren zu deren herstellung.
PT83975B (pt) Processo para a preparacao de derivados de 5-aminoalquil-beta-carbolinas e de composicoes farmaceuticas que os contem
ATE2527T1 (de) Thienylbenzoesaeurederivate, verfahren zu ihrer herstellung und pharmazeutische praeparate auf basis dieser verbindungen.
FI102280B1 (fi) Menetelmä terapeuttisesti käyttökelpoisten 2-formyylibentsyylifosfonihappojohdannaisten valmistamiseksi
DK161021C (da) Analogifremgangsmaade til fremstilling af fluorerede diaminoheptynderivater eller farmaceutisk acceptable salte deraf
DE68922596D1 (de) 3-(3-Ethyl-1,2,4-oxadiazol-5-yl)-1-azabicycloheptan, Verfahren zu seiner Herstellung und dieses enthaltende pharmazeutische Zubereitungen.
DK151332C (da) Analogifremgangsmaade til fremstilling af dibenzoxazonin-, dibenzoxazecin- eller dibenzoxaazacykloundecanderivater eller de tilsvarende thia- eller azaderivater eller farmaceutisk acceptable syreadditionssalte deraf
ES476232A1 (es) Procedimiento para la obtencion de derivados del fosfonilu- reidobenceno.
NO931091L (no) Analoger av sykloinopeptid a og anvendelse derav
ATE87004T1 (de) Fluor enthaltende makrolid-verbindungen, pharmazeutische zusammensetzungen, welche diese enthalten und ihre verwendung fuer die herstellung von arzneimitteln.